An opportunity for further control of hepatitis B in China?

Lancet Infect Dis. 2016 Jan;16(1):10-11. doi: 10.1016/S1473-3099(15)00245-5. Epub 2015 Aug 9.

Authors

Claudia Vellozzi¹, Francisco Averhoff²

Affiliations

¹ Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Viral Hepatitis, Atlanta, GA 30333, USA. Electronic address: [email protected].
² Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Viral Hepatitis, Atlanta, GA 30333, USA.

PMID: 26268688
DOI: 10.1016/S1473-3099(15)00245-5

No abstract available

Publication types

Comment

MeSH terms

Hepatitis B / epidemiology*
Hepatitis B Antibodies / blood*
Hepatitis B virus / immunology*
Humans
Male

Substances

Hepatitis B Antibodies